To Rechallenge, Or Not To Rechallenge
Oct 17, 2019•15 min
Episode description
Weighing the risks & benefits of immunotherapy rechallenge in patients with a prior immune-related adverse event (irAE). Reference: https://www.ncbi.nlm.nih.gov/pubmed/31461381
For the best experience, listen in Metacast app for iOS or Android
